Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Resch, G; Schaberl-Moser, R; Kier, P; Kopetzky, G; Scheithauer, W; Sliwa, T; Greil, R; Nösslinger, T; Mayrbäurl, B; Thaler, J.
Infusion reactions to the chimeric EGFR inhibitor cetuximab--change to the fully human anti-EGFR monoclonal antibody panitumumab is safe.
Ann Oncol. 2011; 22(2): 486-487.
Doi: 10.1093/annonc/mdq744
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
-
Schaberl-Moser Renate
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Find related publications in this database (using NLM MeSH Indexing)
-
Antibodies, Monoclonal - administration and dosage
-
Antineoplastic Agents - administration and dosage
-
Colorectal Neoplasms - drug therapy
-
Humans -
-
Infusions, Intravenous -
-
Neoplasm Metastasis -
-
Receptor, Epidermal Growth Factor - antagonists and inhibitors